1. Abelö A, Andersson TB, Antonsson M, Naudot AK, Skånberg I, Weidolf L (2000) Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes. Drug Metab Dispos 28(8):966–972. https://dmd.aspetjournals.org/content/28/8/966.long
2. Abernethy DR, Wesche DL, Barbey JT, Ohrt C, Mohanty S, Pezzullo JC, Schuster BG (2001) Stereoselective halofantrine disposition and effect: concentrationrelated QTc prolongation. Br J Clin Pharmacol 51(3):231–237. https://doi.org/10.1046/j.1365-2125.2001.00351.x
3. Akamine Y (2015) Determinants of the stereoselective pharmacokinetics of fexofenadine. Yakugaku Zasshi 135(3):473–481. https://doi.org/10.1248/yakushi.14-00218
4. Alekseev VV (1998) Optical isomerism and pharmacological activity of drugs. Soros Obrazovat Zh 1:49–55
5. Ariëns EJ (1983) Stereoselectivity of bioactive agents: general aspects. In: Ariens EJ, Soudijn W, Timmermans PBMWM (eds) Stereochemistry and biological activity of drugs., Blackwell Scientific, Oxford, USA, pp 11–33